JPMorgan Chase & Co. increased its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report) by 175.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 231,957 shares of the company’s stock after buying an additional 147,784 shares during the period. JPMorgan Chase & Co. owned about 0.47% of Nu Skin Enterprises worth $1,710,000 at the end of the most recent quarter.
Several other hedge funds have also added to or reduced their stakes in the business. The Manufacturers Life Insurance Company boosted its position in Nu Skin Enterprises by 6.0% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 19,262 shares of the company’s stock worth $203,000 after buying an additional 1,096 shares during the period. Ensign Peak Advisors Inc boosted its position in Nu Skin Enterprises by 9.0% during the 2nd quarter. Ensign Peak Advisors Inc now owns 19,976 shares of the company’s stock worth $211,000 after buying an additional 1,650 shares during the period. Vanguard Personalized Indexing Management LLC boosted its position in Nu Skin Enterprises by 37.0% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 14,658 shares of the company’s stock worth $154,000 after buying an additional 3,962 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Nu Skin Enterprises by 3.7% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 116,424 shares of the company’s stock worth $858,000 after buying an additional 4,125 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new stake in Nu Skin Enterprises during the 2nd quarter worth approximately $47,000. 82.84% of the stock is currently owned by institutional investors and hedge funds.
Nu Skin Enterprises Stock Down 4.0 %
Shares of NYSE NUS opened at $7.03 on Thursday. The company has a market capitalization of $349.21 million, a P/E ratio of -3.39 and a beta of 1.19. Nu Skin Enterprises, Inc. has a 52-week low of $5.95 and a 52-week high of $19.30. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.20 and a current ratio of 1.93. The company’s 50 day moving average price is $7.18 and its 200-day moving average price is $7.90.
Nu Skin Enterprises Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were given a dividend of $0.06 per share. The ex-dividend date was Friday, November 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.42%. Nu Skin Enterprises’s payout ratio is presently -11.59%.
Wall Street Analysts Forecast Growth
NUS has been the topic of several recent research reports. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th. DA Davidson dropped their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating on the stock in a research report on Friday, December 20th. Finally, Citigroup dropped their price target on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating on the stock in a research report on Tuesday, October 22nd.
Get Our Latest Research Report on NUS
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also
- Five stocks we like better than Nu Skin Enterprises
- What Investors Need to Know About Upcoming IPOs
- Oracle Announces Game-Changing News for the AI Industry
- Technology Stocks Explained: Here’s What to Know About Tech
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Why Invest in High-Yield Dividend Stocks?
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS – Free Report).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.